Clinical Trials on Moderate Asthma

Total 5413 results

KoBioLabs
Novotech (Australia) Pty Limited

Completed

Study of Multiple Ascending Dose of KBL693 in Healthy Participants

Moderate to Severe Asthma

Australia
Societa Italiana di Pneumologia
Società Italiana di Allergologia, Asma e Immunologia Clinica

Recruiting

MANI Real-life Perspective Observatory (MANI)

Asthma | Moderate Asthma | Mild Asthma

Italy
SamA Pharmaceutical Co., Ltd

Completed

Safety and Efficacy of SA09012 in Asthma

Mild to Moderate Bronchial Asthma

Korea, Republic of
Eurofarma Laboratorios S.A.

Not yet recruiting

Non-Inferiority,Combination Formoterol/FluticasonexAlenia®Formoterol/Budesonide for Asthma in Brazil (FORASMA)

Moderate Asthma

Brazil
Regeneron Pharmaceuticals
Sanofi

Completed

Study of Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of REGN3500 in Adults With Moderate Asthma

Asthma | Moderate Asthma

United Kingdom
Emphycorp

Terminated

Safety and Efficacy Study of the Use of Sodium Pyruvate Bronchodilation in Asthmatics

Moderate Asthma

United States
Koneksa Health

Completed

Study Comparing At-Home Mobile Spirometry to In-Clinic in Moderate Asthma Participants Taking Long-Acting Beta Agonist (LEARN)

Moderate Asthma

United States
Guangzhou Institute of Respiratory Disease

Unknown

Effect of Bronchial Thermoplasty on Moderate Bronchial Asthma in China

Moderate Asthma

China
Lu Yuan Lee
National Institute of Allergy and Infectious Diseases (NIAID)

Withdrawn

Expressions of TRPV1 in Airway of Asthmatics (TRPV1)

Pulmonary Atelectasis | Severe Persistent Asthma | Moderate Persistent Asthma | Nodule Solitary Pulmonary

United States
MedImmune LLC

Terminated

A Study to Assess Pharmacokinetics, Safety and Tolerability of Multiple Doses of CAT-354 in Subjects With Moderate Asthma

Moderate Asthma

United Kingdom
University of North Carolina, Chapel Hill
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Phase I Assessment of Hypertonic Saline in Moderate to Severe Asthmatics

Moderate to Severe Asthma

United States
Humanigen, Inc.

Completed

Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids (KB003-04)

Moderate-to-Severe Asthma

France, United Kingdom, United States, Australia, Poland, Ukraine
Tanta University

Active, not recruiting

The Possible Efficacy and Safety of L-carnitine and Biotin as Adjunctive Therapies in Children With Moderate Persistent Asthma

Moderate Persistent Asthma

Egypt
AstraZeneca

Completed

NIS-observe Treatment Efficacy in Maintaining Symptoms Control in Moderate/Severe Asthma With Symbicort SMART

Moderate/Severe Asthma

Romania
The First Affiliated Hospital with Nanjing Medical...

Recruiting

A Clinical Study of Omalizumab in the Treatment of Allergic Asthma(ESSENCE) (ESSENCE)

Moderate to Severe Allergic Asthma

China
Genentech, Inc.

Terminated

A Study to Assess the Impact of Omalizumab on Exercise Capacity, Physical Activity, and Sleep Quality in Participants With Moderate to Severe Allergic Asthma (EDURO)

Moderate-to-severe Allergic Asthma

United States
AstraZeneca

Recruiting

A Study To Evaluate The Treatment Pattern Of Moderate-to-Severe Asthma Patients In China (PRESENT)

Moderate-to-Severe Asthma

China
University of California, San Diego
Mayo Clinic; National Heart, Lung, and Blood Institute (NHLBI); Yale University; Brigham and Women's Hospital and other collaborators

Recruiting

Leveraging Pharmacogenomics in Asthma for Predication, Mechanism and Endotyping (EPIPHANY)

Moderate to Severe Asthma

United States
Incyte Corporation

Recruiting

A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Inadequately Controlled Moderate to Severe Asthma

Moderate to Severe Asthma

Korea, Republic of, United States, Spain, Poland, Japan, Canada, Germany, Belgium, Argentina
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Recruiting

A Study of CM326 in Subjects With Moderate to Severe Asthma

Moderate to Severe Asthma

China
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Recruiting

A Study of CM310 in Subjects With Moderate to Severe Asthma

Moderate to Severe Asthma

China
SkyePharma AG
Abbott

Completed

Single-dose Crossover Study to Evaluate the Early Bronchodilating Effect of FlutiForm HFA pMDI in Adult Subjects With Mild to Moderate Asthma

Mild to Moderate Asthma

United States
Government Medical College, Bhavnagar

Completed

Controller Medications in the Management of Bronchial Asthma

Moderate to Severe Persistent Bronchial Asthma

India
PT Otsuka Indonesia

Completed

Nebulized Procaterol Versus Nebule Salbutamol for the Treatment of Moderate Acute Asthma

Moderate Acute Asthma

Indonesia
Cytos Biotechnology AG

Terminated

CYT003-QbG10, a TLR9-agonist, for Treatment of Uncontrolled Moderate to Severe Allergic Asthma

Moderate to Severe Allergic Asthma

United States, Czech Republic, Germany, Hungary, Israel, Poland, Russian Federation, Ukraine
California Allergy and Asthma Medical Group, Inc.

Unknown

Efficacy and Safety of Activation Energy Serum (AES) Versus Placebo in Persistent Asthma.

Mild to Moderate Persistent Asthma

United States
Oxagen Ltd

Completed

OC000459 Dose Finding Study in Patients With Mild to Moderate Persistent Asthma

Mild to Moderate Persistent Asthma

Bulgaria, Russian Federation, Hungary, Romania, Ukraine, Poland
Cinnagen

Completed

Efficacy and Safety of Zerafil® (Omalizumab) in Participants With Uncontrolled Moderate to Severe Allergic Asthma

Allergic Asthma | Uncontrolled Moderate to Severe

Iran, Islamic Republic of
AstraZeneca

Completed

Gemini Symbicort pMDI

Mild or Moderate Asthma
Poitiers University Hospital

Recruiting

Early High-flow Oxygen Therapy With nebuLized Beta-2-agonist Using a Vibrating Mesh for the Management of Moderate to Severe Asthma Exacerbation in the Emergency Department (EOLE)

Moderate Asthma Exacerbation | Severe Asthma Exacerbation

France
Indiana University

Recruiting

5HTP Regulation Of Asthma In Children

Mild or Moderate Asthma With Allergic Sensitization

United States
Assistance Publique - Hôpitaux de Paris

Completed

Ulna Length in Black Children (ULNOIR)

Ulna Length in Otherwise Healthy Children (With the Exception of Mild to Moderate Asthma)

France
Suzhou Connect Biopharmaceuticals, Ltd.

Completed

Efficacy and Safety of CBP-201 in Patients With Moderate to Severe Persistent Asthma With Type 2 Inflammation

Moderate to Severe Persistent Asthma

United States, China, Hungary, Korea, Republic of, Poland
Tripler Army Medical Center
U.S. Army Medical Research Acquisition Activity

Unknown

Asthma In-Home Monitoring (AIM) Trial

Mild, Moderate and Severe Persistent Asthma as Defined by NHLBI-2 Guidelines

United States
Optinose US Inc.

Completed

A Study to Compare the Bioavailability Intranasal Administration of 200 and 400 µg or 400 µg Alone of OPTINOSE™ FLUTICASONE With 440 µg of Flovent® HFA (Fluticasone Propionate) Inhalation Aerosol (Part 2)

Mild to Moderate Asthma

Ireland
Novartis Pharmaceuticals
Genentech, Inc.

Completed

Observational and Epidemiologic Study of the Disease Course and Unmet Needs in Children With Symptomatic Moderate to Severe Allergic Asthma

Moderate to Severe Allergic Asthma

United States, Puerto Rico
Beer, Kenneth R., M.D., PA
Medicis Pharmaceutical Corporation

Completed

Upper Facial Remodeling With Perlane-L and Dysport (DPL-2010)

Mild to Moderate Temporal Atrophy | Moderate to Severe Glabellar Rhytids | Moderate to Severe Periorbital Rhytids

United States
AstraZeneca
Amgen

Completed

Study to Assess the Effect of Tezepelumab on the Immune Response to Influenza Vaccination in Participants With Asthma (VECTOR)

Moderate to Severe Asthma

United States
National Taiwan University Hospital

Unknown

GABA Antagonist to Improve Reversal of Anesthesia With High-density EEG Surveillance

Colonoscopy | Moderate Sedation

Taiwan
University of Utah

Terminated

Moderate Sedation Educational Software

Moderate Sedation Training

United States
Evergreen General Hospital, Taiwan

Completed

Optimal Procedural Sequence in Same-day Bidirectional Endoscopy: A Prospective Randomized Controlled Study

Endoscopy | Moderate Sedation
Children's Hospital of Michigan

Completed

Optimal Dosing of Ketamine for Procedural Sedation and Analgesia in Children

Moderate, Deep Sedation
University of Jena

Completed

Intervention With n3 LC-PUFA-supplemented Yogurt

Moderate Hypertriacylglycerolemic Subjects

Germany
I.M. Sechenov First Moscow State Medical University

Completed

Sedation and Neuromediators Concentration

Deep Sedation | Moderate Sedation

Russian Federation
Daewoong Pharmaceutical Co. LTD.

Completed

Evaluation Onset Time of DWP450-004 and Safety in Moderate-severe Glabellar Lines

Moderate-severe Glabellar Lines
University of Texas Southwestern Medical Center
Forest Laboratories

Completed

Treatment of Outpatients With Severe Asthma and Moderate or Severe Major Depressive Disorder

Severe Asthma | Moderate or Severe Major Depressive Disorder

United States
AbbVie

Recruiting

Study to Evaluate the Effectiveness of Risankizumab in Participants With a Recent Diagnosis of Moderate Plaque Psoriasis in a Real-life Setting in Greece (REDEFINE)

Psoriasis | Moderate Plaque Psoriasis | Moderate Psoriasis

Greece
Aqpha Medical B.V.

Not yet recruiting

Safety and Performance of PTMC Dermal Filler

Moderate to Severe Nasolabial Fold
Daewoong Pharmaceutical Co. LTD.

Completed

DWP450 for Treating Moderate to Severe Glabellar Lines

Moderate to Severe Glabellar Lines

China
Galderma R&D

Completed

A Study to Evaluate the Efficacy and Safety of QM1114-DP for the Treatment of Moderate to Severe Glabellar Lines

Moderate to Severe Glabellar Lines

China

Clinical Trials on Moderate Asthma

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Zimbabwe

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations